Startup Says Its Blood Test Can Detect Early-Stage Lung Cancer
The Fellowship | September 10, 2019
An Israeli startup may have a promising start in using a blood test to discover early signs of lung cancer reports the Times of Israel:
Israeli startup Savicell Diagnostics has jumped into the emerging market of lung cancer detection, saying its blood tests can discover signs of the disease at its initial stage.
The “revolutionary” ImmunoBiopsy test is minimally invasive and easily available in a world of rising healthcare expenditure, said the company’s CEO and president Giora Davidovits.